Austin I Kim

This study is testing a combination of three drugs—acalabrutinib, venetoclax, and obinutuzumab—for people with mantle cell lymphoma, a type of blood cancer. It aims to see if this combination is safe and effective for patients whose cancer has come back after treatment or who hav…